These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

208 related items for PubMed ID: 1993850

  • 1. Evidence for the functional binding in vivo of tumor rejection antigens to antigen-presenting cells in tumor-bearing hosts.
    Shimizu J, Zou JP, Ikegame K, Katagiri T, Fujiwara H, Hamaoka T.
    J Immunol; 1991 Mar 01; 146(5):1708-14. PubMed ID: 1993850
    [Abstract] [Full Text] [Related]

  • 2. Induction of tumor-specific in vivo protective immunity by immunization with tumor antigen-pulsed antigen-presenting cells.
    Shimizu J, Suda T, Yoshioka T, Kosugi A, Fujiwara H, Hamaoka T.
    J Immunol; 1989 Feb 01; 142(3):1053-9. PubMed ID: 2464022
    [Abstract] [Full Text] [Related]

  • 3. Induction of tumor-specific in vivo protective immunity by immunization with tumor antigen-pulsed antigen-presenting cells.
    Hamaoka T, Shimizu J, Suda T, Fujiwara H.
    Princess Takamatsu Symp; 1988 Feb 01; 19():265-75. PubMed ID: 3269360
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Cell-mediated immune responses to syngeneic ultraviolet-induced tumours. V. Assessment of accessory and antigen-presenting cell capabilities of normal and ultraviolet-irradiated mice in the generation of anti-tumour cytotoxic effector cells in vitro.
    Lynch DH, Gurish MF, Daynes RA.
    Immunology; 1982 Sep 01; 47(1):49-59. PubMed ID: 6981587
    [Abstract] [Full Text] [Related]

  • 9. A role of interferon-gamma (IFN-gamma) in tumor immunity: T cells with the capacity to reject tumor cells are generated but fail to migrate to tumor sites in IFN-gamma-deficient mice.
    Nakajima C, Uekusa Y, Iwasaki M, Yamaguchi N, Mukai T, Gao P, Tomura M, Ono S, Tsujimura T, Fujiwara H, Hamaoka T.
    Cancer Res; 2001 Apr 15; 61(8):3399-405. PubMed ID: 11309299
    [Abstract] [Full Text] [Related]

  • 10. In vivo treatment with anti-I-A antibodies: differential effects on Ia antigens and antigen-presenting cell function of spleen cells and epidermal Langerhans cells.
    Aberer W, Kruisbeek AM, Shimada S, Katz SI.
    J Immunol; 1986 Feb 01; 136(3):830-6. PubMed ID: 3455705
    [Abstract] [Full Text] [Related]

  • 11. A pivotal role for CC chemokine receptor 5 in T-cell migration to tumor sites induced by interleukin 12 treatment in tumor-bearing mice.
    Uekusa Y, Yu WG, Mukai T, Gao P, Yamaguchi N, Murai M, Matsushima K, Obika S, Imanishi T, Higashibata Y, Nomura S, Kitamura Y, Fujiwara H, Hamaoka T.
    Cancer Res; 2002 Jul 01; 62(13):3751-8. PubMed ID: 12097285
    [Abstract] [Full Text] [Related]

  • 12. Recovery of antitumor CD4+ T cell responsiveness, suppressed in the tumor-bearing state, by release from tumor burden.
    Zou JP, Nagata T, Yamamoto N, Ono S, Fujiwara H, Hamaoka T.
    J Cancer Res Clin Oncol; 1994 Jul 01; 120(5):279-85. PubMed ID: 7907334
    [Abstract] [Full Text] [Related]

  • 13. Administration of IL-12 induces a CD3+ CD4- CD8- B220+ lymphoid population capable of eliciting cytolysis against Fas-positive tumor cells.
    Tsutsui T, Mu J, Ogawa M, Yu WG, Suda T, Nagaga S, Saji F, Murata Y, Fujiwara H, Hamaoka T.
    J Immunol; 1997 Sep 15; 159(6):2599-605. PubMed ID: 9300678
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Cytotoxic T-cell-mediated antitumor effect of levamisole against murine syngeneic fibrosarcoma.
    Gomi K, Morimoto M, Nomoto K.
    Cancer Res; 1982 Oct 15; 42(10):4197-202. PubMed ID: 6980702
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. An essential role of antigen-presenting cell/T-helper type 1 cell-cell interactions in draining lymph node during complete eradication of class II-negative tumor tissue by T-helper type 1 cell therapy.
    Chamoto K, Wakita D, Narita Y, Zhang Y, Noguchi D, Ohnishi H, Iguchi T, Sakai T, Ikeda H, Nishimura T.
    Cancer Res; 2006 Feb 01; 66(3):1809-17. PubMed ID: 16452242
    [Abstract] [Full Text] [Related]

  • 18. Multiple roles of interferon-gamma in the mediation of interleukin 12-induced tumor regression.
    Ogawa M, Yu WG, Umehara K, Iwasaki M, Wijesuriya R, Tsujimura T, Kubo T, Fujiwara H, Hamaoka T.
    Cancer Res; 1998 Jun 01; 58(11):2426-32. PubMed ID: 9622084
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.